Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019

血行動態モニタリングシステムの世界市場:装置、消耗品、侵襲型、最小侵襲型、非侵襲型

◆タイトル:Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019
◆商品コード:MAM-MD-3211
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年3月5日
◆ページ数:153
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療デバイス
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、血行動態モニタリングシステムの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、産業動向、市場シェア分析、市場環境分析、製品別分析、種類別分析、需要先別分析、地域別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。

Over the years, the hemodynamic monitoring systems market has witnessed various technological advancements in order to better serve the critically ill patients. These advancements have led to the development of minimally invasive and noninvasive hemodynamic monitoring systems with an aim to reduce pain, increase comfort, and most importantly reduce infectious diseases, primarily sepsis.

In 2014, the disposables segment accounted for the largest share of the global hemodynamic monitoring systems market, by product; the invasive hemodynamic monitoring systems segment accounted for the largest share of the hemodynamic monitoring systems market, by type; while the hospitals segment accounted for a major share of the hemodynamic monitoring system market, by end user.

In 2014, North America accounted for the largest share of the global hemodynamic monitoring systems market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the hemodynamic monitoring systems market is expected to experience the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of hemodynamic monitoring systems.

The global hemodynamic monitoring systems market witnesses high competitive intensity as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographical expansions, and acquisitions) to increase their market shares and to establish a strong foothold in the global market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the hemodynamic monitoring systems market. The report analyzes hemodynamic monitoring systems by product, by type, and by end-user

• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the hemodynamic monitoring systems market

• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various hemodynamic monitoring system technologies across regions

• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the hemodynamic monitoring systems market

• Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the hemodynamic monitoring systems market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 MARKET SCOPE 19
1.3.1 MARKETS COVERED 19
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY & PRICING 20
1.5 LIMITATIONS 20
1.6 STAKEHOLDERS 20

2 RESEARCH METHODOLOGY 21
2.1 RESEARCH DATA 21
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 22
2.2.1 SECONDARY RESEARCH 22
2.2.1.1 Key data from secondary sources 22
2.2.2 PRIMARY RESEARCH 23
2.2.2.1 Key Industry Insights 24
2.2.2.2 Break Down of Primary Interviews: by Company Type, Designation, and Region 25
2.2.2.3 Key data from primary sources 25
2.2.2.4 Key Insights from primary sources 26
2.3 MARKET SIZE ESTIMATION 26
2.3.1 MARKET FORECAST METHODOLOGY 29
2.3.2 MARKET DATA VALIDATION AND TRIANGULATION 29
2.4 ASSUMPTIONS 30

3 EXECUTIVE SUMMARY 31
3.1 INTRODUCTION 31
3.2 CURRENT SCENARIO 32
3.3 FUTURE OUTLOOK 33
3.4 CONCLUSION 34

4 PREMIUM INSIGHTS 35
4.1 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET 35
4.2 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION AND TYPE 36
4.3 REGIONAL SNAPSHOT OF THE HEMODYNAMIC MONITORING SYSTEMS MARKET 37
4.4 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE (2014 VS. 2019) 37

5 MARKET OVERVIEW 38
5.1 INTRODUCTION 39
5.2 MARKET SEGMENTATION 39
5.3 MARKET DYNAMICS 40
5.3.1 DRIVERS 40
5.3.1.1 Technological advancements in hemodynamic monitoring systems 40
5.3.1.1.1 Noninvasive hemodynamic monitoring systems 41
5.3.1.1.2 Micro-Electro-Mechanical Systems (MEMS) technology 41
5.3.1.2 Growth in the number of people suffering from hypertension 41
5.3.1.3 Growing diabetic population 41
5.3.1.4 Rapid growth in aging population 43
5.3.2 RESTRAINTS 44
5.3.2.1 Risks associated with invasive hemodynamic monitoring 44
5.3.3 OPPORTUNITIES 45
5.3.3.1 India and China to provide significant growth opportunities for the hemodynamic monitoring systems market 45

6 INDUSTRY TRENDS 46
6.1 PORTER’S FIVE FORCES ANALYSIS 46
6.1.1 SUPPLIER’S BARGAINING POWER 46
6.1.1.1 Presence of a large number of suppliers 47
6.1.1.2 Low dependency on single supplier 47
6.1.1.3 Dependency on type of technology 47
6.1.2 BUYER’S BARGAINING POWER 47
6.1.2.1 Large supplier pool 47
6.1.3 THREAT OF NEW ENTRANTS 47
6.1.3.1 Capital-intensive market 47
6.1.3.2 Stronghold of existing players 47
6.1.3.3 Reimbursement coverage 47
6.1.4 THREAT OF SUBSTITUTES 48
6.1.4.1 Lack of alternatives 48
6.1.5 INTENSITY OF COMPETITIVE RIVALRY 48
6.1.5.1 Presence of a large number of small firms 48
6.2 SUPPLY CHAIN ANALYSIS 48
6.2.1 PROMINENT COMPANIES 49
6.2.2 SMALL AND MEDIUM ENTERPRISES 49
6.2.3 END USERS (PATIENTS/HOSPITALS/LABS/CLINICS) 49
6.2.4 KEY INFLUENCERS 50

7 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT 51
7.1 INTRODUCTION 52
7.2 SYSTEMS (MONITORS) 53
7.2.1 DISPLAY SYSTEMS 53
7.2.2 UNIFIED HEMODYNAMIC MONITORING SYSTEMS 53
7.3 DISPOSABLES 56
7.3.1 BALLOON CATHETERS 56
7.3.2 MEASUREMENT PROBES 56
7.3.3 SENSORS 57
7.3.4 GUIDEWIRES 57

8 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE 60
8.1 INTRODUCTION 61
8.2 INVASIVE HEMODYNAMIC MONITORING SYSTEMS 63
8.2.1 APPLICATIONS OF INVASIVE HEMODYNAMIC MONITORING SYSTEMS 63
8.2.2 RISKS ASSOCIATED WITH INVASIVE HEMODYNAMIC MONITORING 63
8.2.3 PRODUCTS 64
8.3 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS 66
8.3.1 APPLICATIONS 67
8.3.2 PRODUCTS 67
8.4 NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS 70
8.4.1 PRODUCTS 70

9 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER 74
9.1 INTRODUCTION 75
9.2 HOSPITALS 77
9.3 CATHETERIZATION LABORATORIES (CATH LABS) 79
9.4 HOME AND AMBULATORY SITES 81

10 HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION 84
10.1 INTRODUCTION 85
10.2 NORTH AMERICA 86
10.2.1 U.S. 89
10.2.1.1 Growing diabetes prevalence to boost the market for hemodynamic monitoring systems 89
10.2.1.2 Reimbursement offerings by companies to drive the market 89
10.2.2 CANADA 90
10.2.2.1 High diabetes prevalence to boost the market for hemodynamic monitoring systems 90
10.3 EUROPE 92
10.3.1 GERMANY 94
10.3.1.1 High Diabetes Prevalence to Accelerate the Market Growth in Germany 94
10.3.1.2 S3 guidelines for intensive care in cardiac surgeries 94
10.3.2 U.K. 96
10.3.2.1 Rising prevalence of diabetes and cardiovascular diseases in the U.K. 96
10.3.3 REST OF EUROPE (ROE) 97
10.3.3.1 SFAR guidelines in France have made ODM (Oesophageal Doppler Monitors) a standard of care in the country 97
10.3.3.2 High diabetes prevalence in Russia, Turkey, Poland, Romania, and Ukraine to propel the market for hemodynamic monitoring systems in these countries 98
10.4 ASIA 99
10.4.1 JAPAN 101
10.4.1.1 Reimbursement offerings by LiDCO Group plc in Japan to propel the market growth 101
10.4.2 CHINA 103
10.4.2.1 High diabetes incidence and rapidly aging population to drive the market in China 103
10.4.3 INDIA 104
10.4.3.1 Increased demand for critical care units and high diabetes incidence to drive the market in India 104
10.4.4 REST OF ASIA 106
10.4.4.1 Adoption of hemodynamic monitoring systems in Vietnam, Singapore, & Malaysia to increase owing to high diabetes prevalence 106
10.4.4.2 Tensys Medical’s strong marketing strategy to bolster the market for noninvasive hemodynamic monitoring in China and Taiwan 106
10.5 REST OF THE WORLD (ROW) 108
10.5.1 LATIN AMERICA 110
10.5.1.1 High diabetes prevalence in Brazil 110
10.5.2 MIDDLE EAST AND AFRICA 111
10.5.2.1 Rise in adoption of hemodynamic monitoring systems in the Middle East & Africa due to high diabetes prevalence 111
10.5.3 PACIFIC COUNTRIES 112
10.5.3.1 High diabetes prevalence and rising incidence of CVDs to drive the growth of hemodynamic monitoring systems in Pacific Countries 112

11 COMPETITIVE LANDSCAPE 115
11.1 OVERVIEW 115
11.2 MARKET SHARE ANALYSIS 116
11.2.1 EDWARDS LIFESCIENCES CORPORATION 116
11.2.2 PULSION MEDICAL SYSTEMS SE 118
11.2.3 LIDCO GROUP PLC 118
11.3 COMPETITIVE SITUATION AND TRENDS 119
11.3.1 AGREEMENTS, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS 120
11.3.2 EXPANSIONS 121
11.3.3 MERGERS AND ACQUISITIONS 122
11.3.4 NEW PRODUCT LAUNCHES 123
11.3.5 OTHERS 124

12 COMPANY PROFILES 125
12.1 INTRODUCTION 125
12.2 CHEETAH MEDICAL, INC. 126
12.3 DELTEX MEDICAL GROUP PLC 128
12.4 EDWARDS LIFESCIENCES CORPORATION 130
12.5 HEMO SAPIENS, INC. 133
12.6 ICU MEDICAL, INC. 134
12.7 LIDCO GROUP PLC 136
12.8 OSYPKA MEDICAL GMBH 139
12.9 PULSION MEDICAL SYSTEMS SE 141
12.10 SCHWARZER CARDIOTEK GMBH 143
12.11 TENSYS MEDICAL, INC. 145
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

13 APPENDIX 147
13.1 DISCUSSION GUIDE 147
13.2 COMPANY DEVELOPMENTS (2012–2014) 150
13.2.1 LIDCO GROUP PLC 150
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 151
13.4 AVAILABLE CUSTOMIZATIONS 151
13.5 RELATED REPORTS 152

LIST OF TABLES

TABLE 1 TOP 10 COUNTRIES/TERRITORIES WITH THE HIGHEST NUMBER OF DIABETICS (AGED 20–79 YEARS), 2013 VS. 2035 42
TABLE 2 GROWTH IN THE NUMBER OF PEOPLE SUFFERING FROM HYPERTENSION DRIVING THE GROWTH OF THE HEMODYNAMICS MONITORING SYSTEMS MARKET 43
TABLE 3 RISKS ASSOCIATED WITH INVASIVE HEMODYNAMIC MONITORING ARE RESTRAINING THE GROWTH OF THE HEMODYNAMIC MONITORING SYSTEMS MARKET 44
TABLE 4 INDIA AND CHINA TO PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES FOR THE HEMODYNAMIC MONITORING SYSTEMS MARKET 45
TABLE 5 HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,
2012–2019 ($MILLION) 52
TABLE 6 HEMODYNAMIC MONITORS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 54
TABLE 7 NORTH AMERICA: HEMODYNAMIC MONITORS MARKET SIZE, BY COUNTRY,
2012–2019 ($MILLION) 54
TABLE 8 EUROPE: HEMODYNAMIC MONITORS MARKET SIZE, BY COUNTRY,
2012–2019 ($MILLION) 55
TABLE 9 ASIA: HEMODYNAMIC MONITORS MARKET SIZE, BY COUNTRY,
2012–2019 ($MILLION) 55
TABLE 10 ROW: HEMODYNAMIC MONITORS MARKET SIZE, BY REGION,
2012–2019 ($MILLION) 55
TABLE 11 HEMODYNAMIC MONITORING DISPOSABLES MARKET SIZE, BY REGION,
2012–2019 ($MILLION) 57
TABLE 12 NORTH AMERICA: HEMODYNAMIC MONITORING DISPOSABLES MARKET SIZE,
BY COUNTRY, 2012–2019 ($MILLION) 58
TABLE 13 EUROPE: HEMODYNAMIC MONITORING DISPOSABLES MARKET SIZE,
BY COUNTRY, 2012–2019 ($MILLION) 58
TABLE 14 ASIA: HEMODYNAMIC MONITORING DISPOSABLES MARKET SIZE,
BY COUNTRY, 2012–2019 ($MILLION) 59
TABLE 15 ROW: HEMODYNAMIC MONITORING DISPOSABLES MARKET SIZE,
BY REGION, 2012–2019 ($MILLION) 59
TABLE 16 HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,
2012–2019 ($MILLION) 61
TABLE 17 HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,
2012–2019 (UNITS) 62
TABLE 18 HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION,
2012–2019 (UNITS) 63
TABLE 19 INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 64
TABLE 20 INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2012–2019 (UNITS) 64
TABLE 21 NORTH AMERICA: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 65
TABLE 22 EUROPE: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY COUNTRY, 2012–2019 ($MILLION) 65
TABLE 23 ASIA: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY COUNTRY, 2012–2019 ($THOUSAND) 66
TABLE 24 ROW: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY REGION, 2012–2019 ($THOUSAND) 66
TABLE 25 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY REGION, 2012–2019 ($MILLION) 67
TABLE 26 MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY REGION, 2012–2019 (UNITS) 68
TABLE 27 NORTH AMERICA: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 68
TABLE 28 EUROPE: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 69
TABLE 29 ASIA: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 69
TABLE 30 ROW: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2012–2019 ($THOUSAND) 70
TABLE 31 NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2012–2019 ($THOUSAND) 71
TABLE 32 NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2012–2019 (UNITS) 71
TABLE 33 NORTH AMERICA: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2012–2019 ($THOUSAND) 72
TABLE 34 EUROPE: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY COUNTRY, 2012–2019 ($THOUSAND) 72
TABLE 35 ASIA: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY COUNTRY, 2012–2019 ($THOUSAND) 72
TABLE 36 ROW: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY REGION, 2012–2019 ($THOUSAND) 73
TABLE 37 HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 75
TABLE 38 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY COUNTRY, 2012–2019 ($MILLION) 76
TABLE 39 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 76
TABLE 40 ASIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION) 76
TABLE 41 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION,
2012–2019 ($MILLION) 77
TABLE 42 HOSPITALS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 78
TABLE 43 NORTH AMERICA: HOSPITALS MARKET SIZE, BY COUNTRY,
2012–2019 ($MILLION) 78
TABLE 44 EUROPE: HOSPITALS MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($MILLION) 78
TABLE 45 ASIA: HOSPITALS MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION) 79
TABLE 46 ROW: HOSPITALS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 79
TABLE 47 CATH LABS MARKET SIZE, BY REGION, 2012–2019 ($THOUSAND) 80
TABLE 48 NORTH AMERICA: CATH LABS MARKET SIZE, BY COUNTRY,
2012–2019 ($THOUSAND) 80
TABLE 49 EUROPE: CATH LABS MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($THOUSAND) 80
TABLE 50 ASIA: CATH LABS MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($THOUSAND) 81
TABLE 51 ROW: CATH LABS MARKET SIZE, BY REGION, 2012–2019 ($THOUSAND) 81
TABLE 52 HOME AND AMBULATORY SITES MARKET SIZE, BY REGION,
2012–2019 ($THOUSAND) 82
TABLE 53 NORTH AMERICA: HOME AND AMBULATORY SITES MARKET SIZE,
BY COUNTRY, 2012–2019 ($THOUSAND) 82
TABLE 54 EUROPE: HOME AND AMBULATORY SITES MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($THOUSAND) 82
TABLE 55 ASIA: HOME AND AMBULATORY SITES MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($THOUSAND) 83
TABLE 56 ROW: HOME AND AMBULATORY SITES MARKET SIZE, BY REGION,
2012–2019 ($THOUSAND) 83
TABLE 57 HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION,
2012–2019 ($MILLION) 85
TABLE 58 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY PRODUCT, 2012–2019 ($MILLION) 87
TABLE 59 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY TYPE, 2012–2019 ($THOUSAND) 88
TABLE 60 NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY END USER, 2012–2019 ($THOUSAND) 88
TABLE 61 U.S.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,
2012–2019 ($MILLION) 89
TABLE 62 U.S.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,
2012–2019 ($THOUSAND) 90
TABLE 63 U.S.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER,
2012–2019 ($THOUSAND) 90
TABLE 64 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 91
TABLE 65 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,
2012–2019 ($THOUSAND) 91
TABLE 66 CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 91
TABLE 67 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 93
TABLE 68 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,
2012–2019 ($THOUSAND) 93
TABLE 69 EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 93
TABLE 70 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 94
TABLE 71 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($THOUSAND) 95
TABLE 72 GERMANY: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 95
TABLE 73 AVERAGE PREVALENCE OF DIABETES IN THE U.K. IN ADULTS IS 6.0% (2013) 96
TABLE 74 U.K.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,
2012–2019 ($MILLION) 96
TABLE 75 U.K.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,
2012–2019 ($THOUSAND) 97
TABLE 76 U.K.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER,
2012–2019 ($THOUSAND) 97
TABLE 77 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,
2012–2019 ($MILLION) 98
TABLE 78 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,
2012–2019 ($THOUSAND) 99
TABLE 79 ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 99
TABLE 80 ASIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,
2012–2019 ($MILLION) 100
TABLE 81 ASIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,
2012–2019 ($THOUSAND) 101
TABLE 82 ASIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 101
TABLE 83 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 102
TABLE 84 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,
2012–2019 ($THOUSAND) 102
TABLE 85 JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 103
TABLE 86 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 103
TABLE 87 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,
2012–2019 ($THOUSAND) 104
TABLE 88 CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 104
TABLE 89 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($MILLION) 105
TABLE 90 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,
2012–2019 ($THOUSAND) 105
TABLE 91 INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 106
TABLE 92 ROA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,
2012–2019 ($MILLION) 107
TABLE 93 ROA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,
2012–2019 ($THOUSAND) 107
TABLE 94 ROA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER,
2012–2019 ($THOUSAND) 107
TABLE 95 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT,
2012–2019 ($THOUSAND) 109
TABLE 96 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE,
2012–2019 ($THOUSAND) 109
TABLE 97 ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2012–2019 ($THOUSAND) 109
TABLE 98 LATIN AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY PRODUCT, 2012–2019 ($THOUSAND) 110
TABLE 99 LATIN AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY TYPE, 2012–2019 ($THOUSAND) 110
TABLE 100 LATIN AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY END USER, 2012–2019 ($THOUSAND) 111
TABLE 101 MIDDLE EAST AND AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2012–2019 ($THOUSAND) 111
TABLE 102 MIDDLE EAST AND AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($THOUSAND) 112
TABLE 103 MIDDLE EAST AND AFRICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END-USER, 2012–2019 ($THOUSAND) 112
TABLE 104 PACIFIC COUNTRIES: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY PRODUCT, 2012–2019 ($THOUSAND) 113
TABLE 105 PACIFIC COUNTRIES: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY TYPE, 2012–2019 ($THOUSAND) 113
TABLE 106 PACIFIC COUNTRIES: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE,
BY END USER, 2012–2019 ($THOUSAND) 114
TABLE 107 AGREEMENTS, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS,
2012–2014 120
TABLE 108 EXPANSIONS, 2012–2014 121
TABLE 109 MERGERS AND ACQUISITIONS, 2012–2014 122
TABLE 110 NEW PRODUCT LAUNCHES, 2012–2014 123
TABLE 111 OTHER DEVELOPMENTS, 2012–2014 124


LIST OF FIGURES

FIGURE 1 GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET: RESEARCH METHODOLOGY STEPS 21
FIGURE 2 SAMPLING FRAME: PRIMARY RESEARCH 24
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 27
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 28
FIGURE 5 RESEARCH DESIGN 29
FIGURE 6 DATA TRIANGULATION METHODOLOGY 30
FIGURE 7 MINIMALLY INVASIVE HEMODYNMAIC MONITORING SYSTEMS MARKET TO WITNESS THE HIGHEST CAGR OF 6.0% FROM 2014 TO 2019 31
FIGURE 8 DISPOSABLES SEGMENT TO GROW AT THE HIGHEST CAGR FROM 2014–2019 33
FIGURE 9 HOSPITALS END-USER SEGMENT DOMINATES THE MARKET 33
FIGURE 10 ASIA IS SLATED TO WITNESS THE HIGHEST GROWTH IN THE HEMODYNAMIC MONITORING SYSTEMS MARKET 34
FIGURE 11 HEMODYNAMIC MONITORING SYSTEMS: MARKET OVERVIEW 35
FIGURE 12 NORTH AMERICA DOMINATED THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN 2014 36
FIGURE 13 ASIA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 37
FIGURE 14 INVASIVE HEMODYNAMIC MONITORING SYSTEMS COMMANDED THE LARGEST SHARE 37
FIGURE 15 HEMODYNAMIC MONITORING SYSTEMS: MARKET SEGMENTATION 39
FIGURE 16 HEMODYNAMIC MONITORING SYSTEMS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 40
FIGURE 17 PORTER’S FIVE FORCES ANALYSIS: HEMODYNAMIC MONITORING SYSTEMS MARKET 46
FIGURE 18 SUPPLY CHAIN: DIRECT DISTRIBUTION IS THE MOST PREFERRED STRATEGY FOLLOWED BY PROMINENT PLAYERS 49
FIGURE 19 DISPOSABLES MARKET EXPECTED TO GROW AT A HIGHER RATE DURING THE FORECAST PERIOD 52
FIGURE 20 INVASIVE HEMODYNAMIC MONITORING SYSTEMS COMMANDED LARGEST MARKET SHARE IN 2014 62
FIGURE 21 HOSPITALS SEGMENT DOMINATED THE HEMODYNAMIC MONITORING SYSTEMS MARKET 75
FIGURE 22 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET 86
FIGURE 23 U.S. TO WITNESS THE HIGHEST GROWTH IN THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN NORTH AMERICA 87
FIGURE 24 GERMANY TO WITNESS THE HIGHEST GROWTH IN THE HEMODYNAMIC MONITORING SYSTEMS MARKET IN EUROPE 92
FIGURE 25 EUROPE: NUMBER OF DIABETICS, BY COUNTRY, 2012 98
FIGURE 26 CHINA IS THE FASTEST-GROWING HEMODYNAMIC MONITORING SYSTEMS MARKET IN ASIA 100
FIGURE 27 ROW ACCOUNTED FOR A SHARE OF 10.5% OF THE GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET IN 2014 108
FIGURE 28 EXPANSIONS WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS BETWEEN 2011 AND 2014 115
FIGURE 29 MARKET SHARE ANALYSIS OF THE GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY KEY PLAYER, 2014 116
FIGURE 30 BATTLE FOR MARKET SHARE: AGREEMENTS, PARTNERSHIPS, JOINT VENTURES, AND COLLABORATIONS WAS THE KEY STRATEGY 119
FIGURE 31 GEOGRAPHICAL REVENUE MIX OF THE TOP 3 PLAYERS 125
FIGURE 32 CHEETAH MEDICAL, INC.: COMPANY AT A GLANCE 126
FIGURE 33 DELTEX MEDICAL GROUP PLC: COMPANY AT A GLANCE 128
FIGURE 34 EDWARDS LIFESCIENCES CORPORATION: COMPANY AT A GLANCE 130
FIGURE 35 HEMO SAPIENS, INC.: COMPANY AT A GLANCE 133
FIGURE 36 ICU MEDICAL, INC.: COMPANY AT A GLANCE 134
FIGURE 37 LIDCO GROUP PLC: COMPANY AT A GLANCE 136
FIGURE 38 OSYPKA MEDICAL GMBH: COMPANY AT A GLANCE 139
FIGURE 39 PULSION MEDICAL SYSTEMS SE: COMPANY AT A GLANCE 141
FIGURE 40 SCHWARZER CARDIOTEK GMBH: COMPANY AT A GLANCE 143
FIGURE 41 TENSYS MEDICAL, INC.: COMPANY AT A GLANCE 145



【レポートのキーワード】

血行動態モニタリングシステム、血行動態モニタリング装置、血行動態モニタリング消耗品、侵襲型血行動態モニタリングシステム、最小侵襲型血行動態モニタリングシステム、非侵襲型血行動態モニタリングシステム、モニタ、バルーンカテーテル、測定プローブ、センサー、ガイドワイヤー

★調査レポート[血行動態モニタリングシステムの世界市場:装置、消耗品、侵襲型、最小侵襲型、非侵襲型] ( Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019 / MAM-MD-3211) 販売に関する免責事項
[血行動態モニタリングシステムの世界市場:装置、消耗品、侵襲型、最小侵襲型、非侵襲型] ( Hemodynamic Monitoring System Market by Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User (Hospitals, Cath Labs, Home and Ambulatory Sites) - Analysis & Global Forecast to 2019 / MAM-MD-3211) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆